Understanding how a specific pathway affects DNA replication and repair

Investigating the roles of the H3.1-TSK/TONSL pathway during chromatin replication

NIH-funded research Yale University · NIH-11100093

This study is looking at a specific pathway in our cells that helps with copying DNA and fixing any mistakes, which is important for preventing diseases like cancer and neurodegenerative disorders, and it’s designed for anyone interested in understanding how our genes stay healthy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionYale University NIH-funded
Lab location1 site (New Haven, United States)
Project IDNIH-11100093 on NIH RePORTER

What this research studies

This research investigates the H3.1-TSK/TONSL pathway, which plays a crucial role in chromatin replication and the transmission of genetic information. By examining how this pathway influences DNA repair and replication processes, the study aims to uncover mechanisms that could lead to genetic mutations associated with diseases like cancer and neurodegenerative disorders. The research employs advanced molecular biology techniques to analyze the interactions between histone variants and DNA repair proteins, providing insights into maintaining genomic stability.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with genetic predispositions to cancer or neurodegenerative disorders, as well as those interested in the underlying mechanisms of these diseases.

Not a fit: Patients with conditions unrelated to genetic mutations or those not affected by cancer or neurodegenerative disorders may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating cancers and neurodegenerative disorders by enhancing our understanding of DNA replication and repair mechanisms.

How similar studies have performed: Previous research has shown promising results in understanding the roles of epigenetic mechanisms in DNA repair, suggesting that this approach could yield valuable insights.

Where this research is happening

New Haven, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.